Identification of recurrent fusion genes across multiple cancer types
Abstract
Chromosome changes are one of the hallmarks of human malignancies. Chromosomal rearrangement is frequent in human cancers. One of the consequences of chromosomal rearrangement is gene fusions in the cancer genome. We have previously identified a panel of fusion genes in aggressive prostate cancers. In this study, we showed that 6 of these fusion genes are present in 7 different types of human malignancies with variable frequencies. Among them, the CCNH‐C5orf30 and TRMT11‐GRIK2 gene fusions were found in breast cancer, colon cancer, non‐small cell lung cancer, esophageal adenocarcinoma, glioblastoma multiforme, ovarian cancer and liver cancer, with frequencies ranging from 12.9% to 85%. In contrast, four other gene fusions (mTOR‐TP53BP1, TMEM135‐CCDC67, KDM4‐AC011523.2 and LRRC59‐FLJ60017) are less frequent. Both TRMT11‐GRIK2 and CCNH‐C5orf30 are also frequently present in lymph node metastatic cancer samples from the breast, colon and ovary. Thus, detecting these fusion transcripts may have significant biological and clinical implications in cancer patient management.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 01, 2019
- Source ID
- 10.1096/fasebj.2019.33.1_supplement.802.32
Entities
People
- George Michalopoulos
- Jianhua Luo
- Yanping Yu
Organizations
- National Cancer Institute
- United States Department of Defense
- University of Pittsburgh
- University of Pittsburgh Cancer Institute